FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3106029492> ?p ?o ?g. }

• W3106029492 endingPage "167" @default.
• W3106029492 startingPage "149" @default.
• W3106029492 abstract "Repository corticotropin injection (RCI; Acthar® Gel) is indicated for the treatment of acute exacerbations of multiple sclerosis (MS) in adults. Despite the well-documented clinical and economic benefits of RCI, many patients are denied use of the therapy by third-party payers. This study aims to understand the demographic and clinical characteristics of MS relapse patients who received a prescription for RCI from their physicians and then were either approved or denied treatment by their insurers. The study compares measurable clinical outcomes and healthcare resource utilization (HCRU) between approved and denied cohorts. A retrospective analysis of adults experiencing MS relapse from January 2015 to December 2018 was conducted using a de-identified open-source claims database [Symphony Health Integrated Dataverse® (IDV)]. Patients were identified using ICD codes for MS and considered to have relapsing/remitting type according to established claims-based methodology. Clinical characteristics and HCRU were analyzed during the year preceding (“baseline”) and the year following (“follow-up”) each patient’s index date, defined as the date of a patient’s first approved RCI claim (for patients with ≥ 1 approved claim) or first denied RCI claim (for patients with only denied claims). Baseline characteristics were reported with unadjusted differences and p values indicating the significance of characteristics between the two cohorts. For outcomes, match-adjusted results were reported using propensity matching to account for underlying differences between cohorts. The study sample included 1902 MS relapse patients with at least one claim for RCI. At baseline, approved patients were slightly older compared to denied patients (mean age 48.0 vs. 47.2), had higher rates of hemiplegia/paraplegia (6.7% vs. 3.3%), greater mobility impairment (17% vs. 11.5%), more exacerbation episodes (66.2% vs. 59.9%), and a higher number of physical therapy/rehab claims (23.5 vs. 14.0), respectively. Outcomes among the matched sample show an increased use of corticosteroids for patients denied access to RCI compared to approved patients (51.1% vs. 42.4%), more exacerbation episodes (36.6% vs. 28.2%), and an increased number of physical therapy/rehab claims (11.5% vs. 9.9%), respectively. The results of this study may aid providers and payers in evaluating scenarios where RCI may be beneficial and improve quality of care for patients experiencing MS relapse." @default.
• W3106029492 created "2020-11-23" @default.
• W3106029492 creator A5004815817 @default.
• W3106029492 creator A5007222032 @default.
• W3106029492 creator A5010859024 @default.
• W3106029492 creator A5018752332 @default.
• W3106029492 creator A5031472718 @default.
• W3106029492 creator A5038050644 @default.
• W3106029492 creator A5039081709 @default.
• W3106029492 creator A5048967528 @default.
• W3106029492 date "2020-11-10" @default.
• W3106029492 modified "2023-10-16" @default.
• W3106029492 title "Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis" @default.
• W3106029492 cites W1507932163 @default.
• W3106029492 cites W1986390122 @default.
• W3106029492 cites W2014094373 @default.
• W3106029492 cites W2034432056 @default.
• W3106029492 cites W2036193982 @default.
• W3106029492 cites W2061326496 @default.
• W3106029492 cites W2065776178 @default.
• W3106029492 cites W2066858700 @default.
• W3106029492 cites W2112165124 @default.
• W3106029492 cites W2132555717 @default.
• W3106029492 cites W2271648806 @default.
• W3106029492 cites W2423086444 @default.
• W3106029492 cites W2765228582 @default.
• W3106029492 cites W2792456710 @default.
• W3106029492 cites W2799536163 @default.
• W3106029492 cites W2800712653 @default.
• W3106029492 cites W2890349017 @default.
• W3106029492 cites W2911658427 @default.
• W3106029492 cites W2953698201 @default.
• W3106029492 cites W2975995412 @default.
• W3106029492 cites W3021445393 @default.
• W3106029492 cites W4230764118 @default.
• W3106029492 cites W4238652850 @default.
• W3106029492 cites W4242097927 @default.
• W3106029492 cites W2769267221 @default.
• W3106029492 doi "https://doi.org/10.1007/s40120-020-00219-y" @default.
• W3106029492 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8140003" @default.
• W3106029492 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33170434" @default.
• W3106029492 hasPublicationYear "2020" @default.
• W3106029492 type Work @default.
• W3106029492 sameAs 3106029492 @default.
• W3106029492 citedByCount "3" @default.
• W3106029492 countsByYear W31060294922021 @default.
• W3106029492 countsByYear W31060294922023 @default.
• W3106029492 crossrefType "journal-article" @default.
• W3106029492 hasAuthorship W3106029492A5004815817 @default.
• W3106029492 hasAuthorship W3106029492A5007222032 @default.
• W3106029492 hasAuthorship W3106029492A5010859024 @default.
• W3106029492 hasAuthorship W3106029492A5018752332 @default.
• W3106029492 hasAuthorship W3106029492A5031472718 @default.
• W3106029492 hasAuthorship W3106029492A5038050644 @default.
• W3106029492 hasAuthorship W3106029492A5039081709 @default.
• W3106029492 hasAuthorship W3106029492A5048967528 @default.
• W3106029492 hasBestOaLocation W31060294921 @default.
• W3106029492 hasConcept C118552586 @default.
• W3106029492 hasConcept C126322002 @default.
• W3106029492 hasConcept C167135981 @default.
• W3106029492 hasConcept C17923572 @default.
• W3106029492 hasConcept C194828623 @default.
• W3106029492 hasConcept C2426938 @default.
• W3106029492 hasConcept C2780640218 @default.
• W3106029492 hasConcept C512399662 @default.
• W3106029492 hasConcept C71924100 @default.
• W3106029492 hasConcept C98274493 @default.
• W3106029492 hasConceptScore W3106029492C118552586 @default.
• W3106029492 hasConceptScore W3106029492C126322002 @default.
• W3106029492 hasConceptScore W3106029492C167135981 @default.
• W3106029492 hasConceptScore W3106029492C17923572 @default.
• W3106029492 hasConceptScore W3106029492C194828623 @default.
• W3106029492 hasConceptScore W3106029492C2426938 @default.
• W3106029492 hasConceptScore W3106029492C2780640218 @default.
• W3106029492 hasConceptScore W3106029492C512399662 @default.
• W3106029492 hasConceptScore W3106029492C71924100 @default.
• W3106029492 hasConceptScore W3106029492C98274493 @default.
• W3106029492 hasIssue "1" @default.
• W3106029492 hasLocation W31060294921 @default.
• W3106029492 hasLocation W31060294922 @default.
• W3106029492 hasOpenAccess W3106029492 @default.
• W3106029492 hasPrimaryLocation W31060294921 @default.
• W3106029492 hasRelatedWork W1501641991 @default.
• W3106029492 hasRelatedWork W2026576563 @default.
• W3106029492 hasRelatedWork W2036193982 @default.
• W3106029492 hasRelatedWork W2065417422 @default.
• W3106029492 hasRelatedWork W213628847 @default.
• W3106029492 hasRelatedWork W2275925001 @default.
• W3106029492 hasRelatedWork W3023923059 @default.
• W3106029492 hasRelatedWork W3196761963 @default.
• W3106029492 hasRelatedWork W4214949305 @default.
• W3106029492 hasRelatedWork W4253956144 @default.
• W3106029492 hasVolume "10" @default.
• W3106029492 isParatext "false" @default.
• W3106029492 isRetracted "false" @default.
• W3106029492 magId "3106029492" @default.
• W3106029492 workType "article" @default.